BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng J, Guo J, North BJ, Wang B, Cui C, Li H, Tao K, Zhang L, Wei W. Functional analysis of deubiquitylating enzymes in tumorigenesis and development. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019;1872:188312. [DOI: 10.1016/j.bbcan.2019.188312] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Liu W, Chen Q, Yuan Y, Wang P. Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.11.002] [Reference Citation Analysis]
2 Lou Y, Ye M, Xu C, Tao F. Insight into the physiological and pathological roles of USP44, a potential tumor target (Review). Oncol Lett 2022;24:455. [PMID: 36380875 DOI: 10.3892/ol.2022.13575] [Reference Citation Analysis]
3 Meng Y, Sun H, Li Y, Zhao S, Su J, Zeng F, Deng G, Chen X. Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer. Int J Biol Sci 2022;18:5475-88. [PMID: 36147464 DOI: 10.7150/ijbs.73790] [Reference Citation Analysis]
4 Wang S, Wang T, Yang Q, Cheng S, Liu F, Yang G, Wang F, Wang R, Yang D, Zhou M, Duan C, Zhang Y, Liu H, Dai Z, Tian K, Liu S. Proteasomal deubiquitylase activity enhances cell surface recycling of the epidermal growth factor receptor in non-small cell lung cancer. Cell Oncol (Dordr) 2022. [PMID: 36129611 DOI: 10.1007/s13402-022-00699-0] [Reference Citation Analysis]
5 Wang Q, Sun Z, Xia W, Sun L, Du Y, Zhang Y, Jia Z. Role of USP13 in physiology and diseases. Front Mol Biosci 2022;9:977122. [DOI: 10.3389/fmolb.2022.977122] [Reference Citation Analysis]
6 Paulmann C, Spallek R, Karpiuk O, Heider M, Schäffer I, Zecha J, Klaeger S, Walzik M, Öllinger R, Engleitner T, Wirth M, Keller U, Krönke J, Rudelius M, Kossatz S, Rad R, Kuster B, Bassermann F. The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma. EMBO J 2022;:e110871. [PMID: 36059274 DOI: 10.15252/embj.2022110871] [Reference Citation Analysis]
7 Zhu M, Wang H, Ding Y, Yang Y, Xu Z, Shi L, Zhang N. Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1. FASEB J 2022;36:e22329. [PMID: 35476303 DOI: 10.1096/fj.202101914RR] [Reference Citation Analysis]
8 Tu R, Ma J, Zhang P, Kang Y, Xiong X, Zhu J, Li M, Zhang C. The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02524-y] [Reference Citation Analysis]
9 Chen R, Pang X, Li L, Zeng Z, Chen M, Zhang S. Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation. Cell Death Dis 2022;13:139. [PMID: 35145062 DOI: 10.1038/s41419-022-04566-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jiang ZY, Hong J, Zhang JH, Wang XF, Ma YS, Xiong ZX, Sun HR, Cheng C, Xie BZ, Liu JB, Ouyang YG, Fu D. Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with p53 Deficiency. Technol Cancer Res Treat 2022;21:15330338221119745. [PMID: 35971329 DOI: 10.1177/15330338221119745] [Reference Citation Analysis]
11 Tang X, Sui X, Weng L, Liu Y. SNAIL1: Linking Tumor Metastasis to Immune Evasion. Front Immunol 2021;12:724200. [PMID: 34917071 DOI: 10.3389/fimmu.2021.724200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wang J, Du T, Lu Y, Lv Y, Du Y, Wu J, Ma R, Xu C, Feng J. VLX1570 regulates the proliferation and apoptosis of human lung cancer cells through modulating ER stress and the AKT pathway. J Cell Mol Med 2021. [PMID: 34854221 DOI: 10.1111/jcmm.17053] [Reference Citation Analysis]
13 Shimizu K, Gi M, Suzuki S, North BJ, Watahiki A, Fukumoto S, Asara JM, Tokunaga F, Wei W, Inuzuka H. Interplay between protein acetylation and ubiquitination controls MCL1 protein stability. Cell Rep 2021;37:109988. [PMID: 34758305 DOI: 10.1016/j.celrep.2021.109988] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Tu R, Kang W, Yang M, Wang L, Bao Q, Chen Z, Dong Y, Wang J, Jiang J, Liu H, Qing G. USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression. Oncogene 2021;40:6417-29. [PMID: 34601505 DOI: 10.1038/s41388-021-02031-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Zhang F, Zhao Y, Sun Y. USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates. J Biol Chem 2021;297:101109. [PMID: 34425107 DOI: 10.1016/j.jbc.2021.101109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kang H, Choi MC, Kim S, Jeong JY, Kwon AY, Kim TH, Kim G, Joo WD, Park H, Lee C, Song SH, Jung SG, Hwang S, An HJ. USP19 and RPL23 as Candidate Prognostic Markers for Advanced-Stage High-Grade Serous Ovarian Carcinoma. Cancers (Basel) 2021;13:3976. [PMID: 34439131 DOI: 10.3390/cancers13163976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zhao Q, Li Y, Du X, Chen X, Jiao Q, Jiang H. Effects of deubiquitylases on the biological behaviors of neural stem cells. Dev Neurobiol 2021. [PMID: 34241974 DOI: 10.1002/dneu.22844] [Reference Citation Analysis]
18 Guo JN, Xia BR, Deng SH, Yang C, Pi YN, Cui BB, Jin WL. Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential. Front Cell Dev Biol 2021;9:680100. [PMID: 34179009 DOI: 10.3389/fcell.2021.680100] [Reference Citation Analysis]
19 Zhang S, Ju X, Yang Q, Zhu Y, Fan D, Su G, Kong L, Li Y. USP47 maintains the stemness of colorectal cancer cells and is inhibited by parthenolide. Biochem Biophys Res Commun 2021;562:21-8. [PMID: 34030041 DOI: 10.1016/j.bbrc.2021.05.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
20 Ma YS, Liu JB, Wu TM, Fu D. New Therapeutic Options for Advanced Hepatocellular Carcinoma. Cancer Control 2020;27:1073274820945975. [PMID: 32799550 DOI: 10.1177/1073274820945975] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
21 Ji J, Yang S, Zu L, Li Y, Li Y. Deubiquitinating enzyme USP41 promotes lung cancer cell proliferation and migration. Thorac Cancer 2021;12:1041-7. [PMID: 33619866 DOI: 10.1111/1759-7714.13843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Liu J, Cheng Y, Zheng M, Yuan B, Wang Z, Li X, Yin J, Ye M, Song Y. Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways. Signal Transduct Target Ther 2021;6:28. [PMID: 33479196 DOI: 10.1038/s41392-020-00418-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
23 Basar MA, Beck DB, Werner A. Deubiquitylases in developmental ubiquitin signaling and congenital diseases. Cell Death Differ 2021;28:538-56. [PMID: 33335288 DOI: 10.1038/s41418-020-00697-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
24 Shi L, Liu J, Peng Y, Zhang J, Dai X, Zhang S, Wang Y, Liu J, Long J. Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission. Mol Oncol 2020;14:3169-83. [PMID: 33070427 DOI: 10.1002/1878-0261.12825] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
25 Shi L, Du D, Peng Y, Liu J, Long J. The functional analysis of Cullin 7 E3 ubiquitin ligases in cancer. Oncogenesis 2020;9:98. [PMID: 33130829 DOI: 10.1038/s41389-020-00276-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
26 Wang L, Li M, Sha B, Hu X, Sun Y, Zhu M, Xu Y, Li P, Wang Y, Guo Y, Li J, Shi J, Li P, Hu T, Chen P. Inhibition of deubiquitination by PR-619 induces apoptosis and autophagy via ubi-protein aggregation-activated ER stress in oesophageal squamous cell carcinoma. Cell Prolif 2021;54:e12919. [PMID: 33129231 DOI: 10.1111/cpr.12919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
27 Bi Y, Cui D, Xiong X, Zhao Y. The characteristics and roles of β-TrCP1/2 in carcinogenesis. FEBS J 2021;288:3351-74. [PMID: 33021036 DOI: 10.1111/febs.15585] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
28 Li F, Hu Q, He T, Xu J, Yi Y, Xie S, Ding L, Fu M, Guo R, Xiao ZJ, Niu M. The Deubiquitinase USP4 Stabilizes Twist1 Protein to Promote Lung Cancer Cell Stemness. Cancers (Basel) 2020;12:E1582. [PMID: 32549341 DOI: 10.3390/cancers12061582] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
29 Zhang P, Li C, Li H, Yuan L, Dai H, Peng Z, Deng Z, Chang Z, Cui CP, Zhang L. Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer. Cell Death Differ 2020;27:3177-95. [PMID: 32483383 DOI: 10.1038/s41418-020-0571-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
30 Lai KP, Chen J, Tse WKF. Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy. Int J Mol Sci 2020;21:E2548. [PMID: 32268558 DOI: 10.3390/ijms21072548] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
31 Liu YZ, Du XX, Zhao QQ, Jiao Q, Jiang H. The expression change of OTUD3-PTEN signaling axis in glioma cells. Ann Transl Med 2020;8:490. [PMID: 32395534 DOI: 10.21037/atm.2020.03.51] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
32 Reavis HD, Drapkin R. The tubal epigenome - An emerging target for ovarian cancer. Pharmacol Ther 2020;210:107524. [PMID: 32197795 DOI: 10.1016/j.pharmthera.2020.107524] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
33 Deng J, Liang L, Yi H, Su T, Yang Z, Nie L, Liu J. USP7 inhibition inhibits proliferation and induces megakaryocytic differentiation in MDS cells by upregulating gelsolin. Br J Haematol 2020;190:418-29. [PMID: 32130729 DOI: 10.1111/bjh.16549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]